INTRODUCTION AND HYPOTHESIS: Catheter-associated urinary tract infections (UTI) are the most common health-care-related infections. We aimed to compare the UTI rate among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter (SPC) and a standard SPC, and identify the risk factors predisposing patients to UTI. METHODS:Patients who were to undergo placement of an SPC as part of pelvic organ prolapse surgery were enrolled between 1 August 2011 and 30 August 2017, and randomized to either standard SPC or silver-alloy SPC. Follow-up was performed at a postoperative visit or via a phone call at 6 weeks. The primary outcome was UTI. RESULTS: Of the 288 patients who were randomized, 127 with standard SPC and 137 with silver-alloy SPC were included in the analysis. Twenty-nine out of 123 women with standard SPC (23.6%) and 24 out of 131 (18.3%) with silver-alloy SPC were diagnosed with UTI within 6 weeks postoperatively (p = 0.30). In univariate analysis, non-white race (odds ratio [OR] 5.36, 95% CI 1.16-24.73) and diabetes (OR 2.80, 95% CI 1.26-6.23) were associated with increased risk of UTI. On multivariate analysis, only diabetes remained an independent risk factor. Comparisons between groups were evaluated using two-sample t test for age, Chi-squared tests for diabetes, and Wilcoxon rank sum test for all other variables. CONCLUSION: There was only a 5% difference in 6-week UTI rates between those who received standard vs silver-alloy SPC; the study was not powered to detect such a small difference. Diabetes was identified as a risk factor for SPC-associated UTI in women undergoing pelvic reconstructive surgeries.
RCT Entities:
INTRODUCTION AND HYPOTHESIS: Catheter-associated urinary tract infections (UTI) are the most common health-care-related infections. We aimed to compare the UTI rate among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter (SPC) and a standard SPC, and identify the risk factors predisposing patients to UTI. METHODS:Patients who were to undergo placement of an SPC as part of pelvic organ prolapse surgery were enrolled between 1 August 2011 and 30 August 2017, and randomized to either standard SPC or silver-alloy SPC. Follow-up was performed at a postoperative visit or via a phone call at 6 weeks. The primary outcome was UTI. RESULTS: Of the 288 patients who were randomized, 127 with standard SPC and 137 with silver-alloy SPC were included in the analysis. Twenty-nine out of 123 women with standard SPC (23.6%) and 24 out of 131 (18.3%) with silver-alloy SPC were diagnosed with UTI within 6 weeks postoperatively (p = 0.30). In univariate analysis, non-white race (odds ratio [OR] 5.36, 95% CI 1.16-24.73) and diabetes (OR 2.80, 95% CI 1.26-6.23) were associated with increased risk of UTI. On multivariate analysis, only diabetes remained an independent risk factor. Comparisons between groups were evaluated using two-sample t test for age, Chi-squared tests for diabetes, and Wilcoxon rank sum test for all other variables. CONCLUSION: There was only a 5% difference in 6-week UTI rates between those who received standard vs silver-alloy SPC; the study was not powered to detect such a small difference. Diabetes was identified as a risk factor for SPC-associated UTI in women undergoing pelvic reconstructive surgeries.
Authors: Ingrid Nygaard; Linda Brubaker; Toby C Chai; Alayne D Markland; Shawn A Menefee; Larry Sirls; Gary Sutkin; Phillipe Zimmern; Amy Arisco; Liyuan Huang; Sharon Tennstedt; Anne Stoddard Journal: Int Urogynecol J Date: 2011-05-11 Impact factor: 2.894
Authors: Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: John B Gebhart; Deborah A Dixon; Emanuel C Trabuco; Christopher J Klingele; Stephanie M Bagniewski; Amy L Weaver Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-02-28
Authors: R W Haley; T M Hooton; D H Culver; R C Stanley; T G Emori; C D Hardison; D Quade; R H Shachtman; D R Schaberg; B V Shah; G D Schatz Journal: Am J Med Date: 1981-04 Impact factor: 4.965
Authors: Robert Pickard; Thomas Lam; Graeme MacLennan; Kath Starr; Mary Kilonzo; Gladys McPherson; Katie Gillies; Alison McDonald; Katherine Walton; Brian Buckley; Cathryn Glazener; Charles Boachie; Jennifer Burr; John Norrie; Luke Vale; Adrian Grant; James N'Dow Journal: Lancet Date: 2012-11-05 Impact factor: 79.321
Authors: Jyothi Manohar; Savannah Hatt; Brigette B DeMarzo; Freida Blostein; Anna E W Cronenwett; Jianfeng Wu; Kyu Han Lee; Betsy Foxman Journal: Am J Infect Control Date: 2019-09-17 Impact factor: 2.918